These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 12625212)

  • 21. The routes to orphan drug designation--our recent experience at the FDA.
    Lev D; Thorat C; Phillips I; Thomas M; Imoisili MA
    Drug Discov Today; 2012 Feb; 17(3-4):97-9. PubMed ID: 22210120
    [No Abstract]   [Full Text] [Related]  

  • 22. Characteristics of efficacy evidence supporting approval of supplemental indications for prescription drugs in United States, 2005-14: systematic review.
    Wang B; Kesselheim AS
    BMJ; 2015 Sep; 351():h4679. PubMed ID: 26400844
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Tropical Disease Priority Review Voucher: A Game-Changer for Tropical Disease Products.
    Berman J; Radhakrishna T
    Am J Trop Med Hyg; 2017 Jan; 96(1):11-13. PubMed ID: 27573627
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Return of alosetron.
    Hyman PE; Garvey TQ
    Expert Opin Drug Saf; 2002 May; 1(1):1-4. PubMed ID: 12904154
    [No Abstract]   [Full Text] [Related]  

  • 25. A pill turned bitter. How a quest for a blockbuster drug went fatally wrong.
    Shapiro JP
    US News World Rep; 2000 Dec; 129(23):54-6. PubMed ID: 11126059
    [No Abstract]   [Full Text] [Related]  

  • 26. Strattera approved to treat ADHD.
    FDA Consum; 2003; 37(2):4. PubMed ID: 12715751
    [No Abstract]   [Full Text] [Related]  

  • 27. What the Orphan Drug Act has done lately for children with rare diseases: a 10-year analysis.
    Thorat C; Xu K; Freeman SN; Bonnel RA; Joseph F; Phillips MI; Imoisili MA
    Pediatrics; 2012 Mar; 129(3):516-21. PubMed ID: 22371464
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lotronex and the FDA: a fatal erosion of integrity.
    Horton R
    Lancet; 2001 May; 357(9268):1544-5. PubMed ID: 11377636
    [No Abstract]   [Full Text] [Related]  

  • 29. FDA OKs two new uses for biologic arthritis drug adalimumab.
    Health News; 2006 Jan; 12(1):2. PubMed ID: 16447312
    [No Abstract]   [Full Text] [Related]  

  • 30. FDA-Approved Drugs to Treat ADHD.
    J Psychosoc Nurs Ment Health Serv; 2023 Mar; 61(3):5-6. PubMed ID: 36881809
    [No Abstract]   [Full Text] [Related]  

  • 31. FDA approves tocilizumab to treat rheumatoid arthritis.
    Thompson CA
    Am J Health Syst Pharm; 2010 Feb; 67(4):254. PubMed ID: 20133526
    [No Abstract]   [Full Text] [Related]  

  • 32. Alosetron approved for treatment of irritable bowel syndrome.
    Miller JL
    Am J Health Syst Pharm; 2000 Mar; 57(6):519. PubMed ID: 10754758
    [No Abstract]   [Full Text] [Related]  

  • 33. Contemporary thoughts on the treatment of irritable bowel syndrome.
    Giaquinta D
    Manag Care Interface; 2002 Aug; 15(8):19-20, 22. PubMed ID: 12229060
    [No Abstract]   [Full Text] [Related]  

  • 34. Do investors value the FDA orphan drug designation?
    Miller KL
    Orphanet J Rare Dis; 2017 Jun; 12(1):114. PubMed ID: 28629392
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New COX-2 arthritis drug receives FDA approval.
    J Gend Specif Med; 2002; 5(2):6. PubMed ID: 11974679
    [No Abstract]   [Full Text] [Related]  

  • 36. Examination of risk evaluation and mitigation strategies and drug safety in the US.
    Rodriguez-Monguio R; Spielberger K; Seoane-Vazquez E
    Res Social Adm Pharm; 2014; 10(1):232-8. PubMed ID: 23611865
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel treatments for rare rheumatologic disorders: analysis of the impact of 30 years of the US orphan drug act.
    Lutz T; Lampert A; Hoffmann GF; Ries M
    Orphanet J Rare Dis; 2016 May; 11(1):60. PubMed ID: 27176041
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methylphenidate transdermal system.
    Mays DA; Findling R
    J Am Acad Child Adolesc Psychiatry; 2005 Dec; 44(12):1223. PubMed ID: 16292112
    [No Abstract]   [Full Text] [Related]  

  • 39. EMEA approves OGS drug rejected by FDA.
    Mitchell P
    Nat Biotechnol; 2002 Sep; 20(9):858-9. PubMed ID: 12205490
    [No Abstract]   [Full Text] [Related]  

  • 40. Analysis of FDA approvals of targeted anticancer combination regimens.
    Brown VT; Cho V; Parkey S
    Am J Health Syst Pharm; 2017 Dec; 74(23):1938-1942. PubMed ID: 29167134
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.